Patent Application
Provisional
App. No. 62/678,223
· Confirmation No. 8608
HEDGEHOG PATHWAY INHIBITION FOR TREATMENT OF HIGH-RISK BASAL CELL CARCINOMA OR HIGH-RISK BASAL CELL CARCINOMA NEVUS SYNDROME
Inventor:
NICHOLAS J. VIRCA
Applicant:
HEDGEPATH PHARMACEUTICALS, INC.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2018-06-05 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2018-05-30 | ADS |
Application Data Sheet | 8 | View | |
| 2018-05-30 | SPEC |
Specification | 47 | View | |
| 2018-05-30 | CLM |
Claims | 3 | View | |
| 2018-05-30 | ABST |
Abstract | 1 | View | |
| 2018-05-30 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2018-05-30 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
NICHOLAS J. VIRCA
TAMPA, FL
Attorneys & Agents of Record
Prosecution
- Customer No.
- 23557
- Docket No.
- HPP.104P
- Confirmation No.
- 8608
from
VIRCA, NICHOLAS J.
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2019-05-23
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 62/678,223
- Filed
- 2018-05-30
External Links